Schumacher TN - Search Results

1

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.

Diehl L, den Boer AT, Schoenberger SP, van der Voort EI, Schumacher TN, Melief CJ, Offringa R, Toes RE. Diehl L, et al. Among authors: schumacher tn. Nat Med. 1999 Jul;5(7):774-9. doi: 10.1038/10495. Nat Med. 1999. PMID: 10395322

2

Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses.

De Bruijn ML, Nieland JD, Schumacher TN, Ploegh HL, Kast WM, Melief CJ. De Bruijn ML, et al. Among authors: schumacher tn. Eur J Immunol. 1992 Nov;22(11):3013-20. doi: 10.1002/eji.1830221137. Eur J Immunol. 1992. PMID: 1425925

3

Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.

De Bruijn ML, Schumacher TN, Nieland JD, Ploegh HL, Kast WM, Melief CJ. De Bruijn ML, et al. Among authors: schumacher tn. Eur J Immunol. 1991 Dec;21(12):2963-70. doi: 10.1002/eji.1830211210. Eur J Immunol. 1991. PMID: 1660811

4

Peptide selection by MHC class I molecules.

Schumacher TN, De Bruijn ML, Vernie LN, Kast WM, Melief CJ, Neefjes JJ, Ploegh HL. Schumacher TN, et al. Nature. 1991 Apr 25;350(6320):703-6. doi: 10.1038/350703a0. Nature. 1991. PMID: 1708852

5

Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.

Schumacher TN, Heemels MT, Neefjes JJ, Kast WM, Melief CJ, Ploegh HL. Schumacher TN, et al. Cell. 1990 Aug 10;62(3):563-7. doi: 10.1016/0092-8674(90)90020-f. Cell. 1990. PMID: 2199065

6

Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells.

Medema JP, Schuurhuis DH, Rea D, van Tongeren J, de Jong J, Bres SA, Laban S, Toes RE, Toebes M, Schumacher TN, Bladergroen BA, Ossendorp F, Kummer JA, Melief CJ, Offringa R. Medema JP, et al. Among authors: schumacher tn. J Exp Med. 2001 Sep 3;194(5):657-67. doi: 10.1084/jem.194.5.657. J Exp Med. 2001. PMID: 11535633 Free PMC article.

7

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.

Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, Toes RE, Offringa R, Melief CJ. Sutmuller RP, et al. Among authors: schumacher tn. J Exp Med. 2001 Sep 17;194(6):823-32. doi: 10.1084/jem.194.6.823. J Exp Med. 2001. PMID: 11560997 Free PMC article.

8

Immunotherapy through TCR gene transfer.

Kessels HW, Wolkers MC, van den Boom MD, van der Valk MA, Schumacher TN. Kessels HW, et al. Among authors: schumacher tn. Nat Immunol. 2001 Oct;2(10):957-61. doi: 10.1038/ni1001-957. Nat Immunol. 2001. PMID: 11577349

9

Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas.

Schepers K, Toebes M, Sotthewes G, Vyth-Dreese FA, Dellemijn TA, Melief CJ, Ossendorp F, Schumacher TN. Schepers K, et al. Among authors: schumacher tn. J Immunol. 2002 Sep 15;169(6):3191-9. doi: 10.4049/jimmunol.169.6.3191. J Immunol. 2002. PMID: 12218137

10

Balancing between antitumor efficacy and autoimmune pathology in T-cell-mediated targeting of carcinoembryonic antigen.

Bos R, van Duikeren S, Morreau H, Franken K, Schumacher TN, Haanen JB, van der Burg SH, Melief CJ, Offringa R. Bos R, et al. Among authors: schumacher tn. Cancer Res. 2008 Oct 15;68(20):8446-55. doi: 10.1158/0008-5472.CAN-08-1864. Cancer Res. 2008. PMID: 18922918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page